is tirzepatide compound ending The FDA has proposed to bar 503B outsourcing facilities from bulk compounding semaglutide and tirzepatide. The shortage-list pathway already closed in 2024 and 2025; this proposal would remove the remaining bulks-list route Compounded vs regular tirzepatide: key
Description
Feb 8, 2026 Two medications
We prioritize patient safety and effectiveness, ensuring each person receives a customized treatment plan aligned with their health goals
Telehealth programs focused on weight or metabolic health
That focus shapes everything from how the intake process is structured to how providers approach dose escalation and ongoing care
While the base-case analysis showed numerical differences in cost of control between tirzepatide and semaglutide, the 95% confidence intervals around the mean estimates overlapped at all thresholds
